Results for tag: "Benzodiazepine Receptor Agonist"

The Benzodiazepine Receptor Agonist market is a subset of the Central Nervous System Drugs market. These drugs are used to treat a variety of conditions, including anxiety, insomnia, seizures, and muscle spasms. They work by binding to the benzodiazepine receptor in the brain, which helps to reduce the activity of certain neurotransmitters. This can help to reduce symptoms of anxiety, insomnia, and other conditions. Benzodiazepine Receptor Agonists are typically prescribed for short-term use, as long-term use can lead to dependence and tolerance. Common side effects include drowsiness, dizziness, and confusion. The Benzodiazepine Receptor Agonist market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more